Tumor suppressor p53: Biology, signaling pathways, and therapeutic targeting

Liz J Hernández Borrero1, Wafik S El-Deiry1

  • 1Laboratory of Translational Oncology and Experimental Cancer Therapeutics, Warren Alpert Medical School, Brown University, Providence, RI 02912, United States of America; Department of Pathology and Laboratory Medicine, Warren Alpert Medical School, Brown University, Providence, RI 02912, United States of America; The Joint Program in Cancer Biology, Brown University and Lifespan Health System, Providence, RI 02912, United States of America; Cancer Center at Brown University, Warren Alpert Medical School, Brown University, Providence, RI 02912, United States of America.

Insights

The TP53 gene is crucial in cancer, acting as a tumor suppressor. Research is advancing our understanding of its complex pathway and exploring therapeutic strategies for mutant TP53 in oncology.

Area of Science:

  • Oncology
  • Cancer Biology
  • Molecular Biology

Background:

  • The TP53 gene is the most frequently mutated gene in human cancers.
  • The p53 pathway is a critical cellular stress response network involved in tumor suppression.
  • Despite extensive research, clinical translation of p53 pathway knowledge remains challenging.

Purpose of the Study:

  • To review current knowledge on the biology and signaling mechanisms of the p53 pathway.
  • To summarize recent advances in therapeutic development targeting the p53 pathway.
  • To highlight the complexities and challenges in the clinical application of p53 research.

Main Methods:

  • Literature review of TP53 research.
  • Analysis of p53 pathway signaling and its components.
  • Summary of therapeutic strategies targeting wild-type and mutant p53.

Main Results:

  • The p53 pathway is a complex network with diverse inputs and outputs.
  • Mutant TP53 has recognized prognostic value in cancer.
  • Therapeutic modulation of p53 (wild-type and mutant) is an ongoing area of development.

Conclusions:

  • Understanding the p53 pathway is vital for cancer biology and oncology.
  • Further research is needed to overcome clinical translation challenges for p53-targeted therapies.
  • Advances in understanding p53 biology are paving the way for novel therapeutic approaches.

Related Concept Videos

Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.8K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.8K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
8.5K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.0K
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
5.4K
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
37.2K